Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
SEDRIC – Structured EDucation for Rehabilitation in Intermittent Claudication
ISRCTN ISRCTN06733130
DOI 10.1186/ISRCTN06733130
ClinicalTrials.gov identifier NCT01776710
EudraCT number
Public title SEDRIC – Structured EDucation for Rehabilitation in Intermittent Claudication
Scientific title Development and piloting of a pragmatic structured education programme that promotes walking in patients with intermittent claudication
Acronym SEDRIC
Serial number at source 13928
Study hypothesis Some people experience a cramp-like leg pain during walking that is relieved only by rest. This is called intermittent claudication and it is a common symptom of peripheral arterial disease. Patients with intermittent claudication struggle to walk, which in turn lowers their quality of life. Medically supervised walking programmes have been shown to improve walking ability and quality of life, but more patients could potentially benefit from physical activity that is self-managed and performed in the community setting. However, little is known about the usefulness of education programmes that promote self-managed physical activity in these patients. This research project aims to develop and test a practical education programme for promoting walking activity in patients with intermittent claudication. We will collect scientific data on the programme's usefulness.

Twenty five patients with intermittent claudication will be interviewed to inform the development of the education programme. At least 12 patients will test the programme to see if any changes are needed. Once we are satisfied with the design of the programme, we will assess the usefulness of the programme in 18 patients. In total, 30 patient volunteers will be randomly assigned to receive either the education programme or usual care.

Possible benefits of the programme to be explored include increased daily steps/physical activity, and improved walking capacity and quality of life. Patients will be followed up until 6 weeks after being allocated to intervention or control groups. Encouraging results from this research will help us plan a much larger trial across several UK institutions.

More details can be found at: http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=13928
Lay summary Background and study aims
Some people experience a cramp-like leg pain during walking that is relieved only by rest. This is called intermittent claudication and it is a common symptom of peripheral arterial disease. Patients with intermittent claudication struggle to walk, which in turn lowers their quality of life. Medically supervised walking programmes have been shown to improve walking ability and quality of life, but more patients could potentially benefit from physical activity that is self-managed and performed in the community setting. However, little is known about the usefulness of education programmes that promote self-managed physical activity in these patients. This research project aims to develop and test a practical education programme for promoting walking activity in patients with intermittent claudication. We will collect scientific data on the programme's usefulness.

Who can participate?
Men and women aged 18-90 years with intermittent claudication.

What does the study involve?
Twenty five patients with intermittent claudication will be interviewed to inform the development of the education programme. At least 12 patients will test the programme to see if any changes are needed. Once we are satisfied with the design of the programme, we will assess the usefulness of the programme in a further 30 patients, who will be randomly assigned to receive either the education programme or usual care.

What are the possible benefits and risks of participating?
Possible benefits of the programme include an increased understanding about peripheral arterial disease. They will also receive support in developing goals and action plans for walking more often, which if adhered to, may result in improved walking capacity and quality of life. All participants will also receive a medical "check-up" from a Consultant Vascular Surgeon during the eligibility screening. Results from this research will help us plan a much larger trial across several UK institutions.
During exertion, there is an increased risk of untoward cardiovascular events such as heart attack. The likelihood of this happening, however, is small. We will minimise the risk of this by only recruiting patients who do not have unstable cardiovascular conditions, by using 12-lead ECG monitoring before, during and after the test, and by ensuring that all tests are supervised by a clinician and a clinical exercise physiologist. We will make it possible for patients to see a Consultant Vascular Surgeon at any point during the trial, if they or the study team have any medical concerns.

Where is the study run from?
Sheffield Hallam University

When is the study starting and how long is it expected to run for?
The study is starting in March 2013 and is expected to end in August 2013.

Who is funding the study?
Bupa Foundation

Who is the main contact?
Dr Garry Tew
g.tew@shu.ac.uk
Ethics approval NRES Committee Yorkshire & The Humber – Sheffield, 25/01/2013, ref: 13/YH/0004
Study design Interventional and Observational; Design type: Treatment, Qualitative
Countries of recruitment United Kingdom
Disease/condition/study domain Topic: Cardiovascular; Subtopic: Cardiovascular (all Subtopics); Disease: Cardiovascular
Participants - inclusion criteria 1. Men and women aged 18-90 years with intermittent claudication due to peripheral arterial disease
2. Stable disease for >3 months
3. Able to provide consent
4. Able to read and speak English to a level allowing satisfactory completion of written questionnaires and to participate in the education intervention
Participants - exclusion criteria 1. Previous endovascular/surgical interventions
2. Scheduled endovascular/surgical intervention
3. Critical limb ischaemia
4. Those whose function is uniquely impaired, e.g. wheelchair-bound patients and patients with lower-extremity amputation(s).
5. Presence of contraindications to exercise or co-morbidities that limit exercise performance to a greater extent than the intermittent claudication (e.g. severe arthritis)
6. Major surgery, myocardial infarction or stroke/TIA in the previous 6 months
7. Patients who already perform greater than 30 min of structured exercise three times weekly (self-reported)
Anticipated start date 01/03/2013
Anticipated end date 31/08/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants UK Sample Size: 55
Interventions Structured education programme, The structured education intervention will comprise a 3-hour education workshop delivered by two trained facilitators and a follow-up telephone call 2 weeks later. The aims of the education programme are to enhance patients' understanding of peripheral arterial disease and intermittent claudication, and to support patients in increasing their daily walking activity. Key behaviour change techniques that will be incorporated will include goal setting, action planning, barrier identification/problem.
Primary outcome measure(s) Feasibility (recruitment, retention, compliance, acceptability) Timepoint(s): Baseline and 6 weeks
Secondary outcome measure(s) 1. Claudication onset and maximum walking distances on 6-minute corridor walk test; Timepoint(s): Baseline and 6 weeks
2. Claudication onset and maximum walking distances on incremental treadmill walking test; Timepoint(s): Baseline and 6 weeks
3. Daily steps and physical activity; Timepoint(s): Baseline and 6 weeks
4. Health-related quality of life; Timepoint(s): Baseline and 6 weeks
5. Psychological constructs representing the key mediators of behaviour change; Timepoint(s): Baseline and 6 weeks 6. Self-reported ambulatory ability; Timepoint(s): Baseline and 6 weeks
Sources of funding Bupa Foundation (UK)
Trial website
Publications
Contact name Dr  Garry  Tew
  Address Centre for Sport and Exercise Science
Sheffield Hallam University
A125 Collegiate Hall
Collegiate Crescent
  City/town Sheffield
  Zip/Postcode S10 2BP
  Country United Kingdom
  Email g.tew@shu.ac.uk
Sponsor Sheffield Hallam University (UK)
  Address c/o Brian Littlejohn
The Centre for Sport and Exercise Science
Faculty of Health and Wellbeing
City Campus
Howard Street
  City/town Sheffield
  Zip/Postcode S1 1WB
  Country United Kingdom
  Sponsor website: http://www.shu.ac.uk/
Date applied 28/02/2013
Last edited 01/03/2013
Date ISRCTN assigned 28/02/2013
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.